{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:35:02Z","timestamp":1792798502472,"version":"4.5.0"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05348-9","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T08:14:36Z","timestamp":1762935276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Microbiota-Derived SCFAs in Multiple Sclerosis: From Immune Priming to Neurodegeneration"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1678-4180","authenticated-orcid":false,"given":"Vivek Kumar","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"5348_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Br\u00fcck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707\u2013717","journal-title":"Ann Neurol"},{"key":"5348_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","volume":"31","author":"BD Trapp","year":"2008","unstructured":"Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247\u2013269","journal-title":"Annu Rev Neurosci"},{"key":"5348_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1177\/1352458517694432","volume":"23","author":"G Kobelt","year":"2017","unstructured":"Kobelt G, Thompson A, Berg J, Gannedahl M, Eriksson J (2017) New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler 23:1123\u20131136","journal-title":"Mult Scler"},{"key":"5348_CR4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041374","volume":"17","author":"MD Kornberg","year":"2025","unstructured":"Kornberg MD, Calabresi PA (2025) Multiple sclerosis and other acquired demyelinating diseases of the central nervous system. Cold Spring Harb Perspect Biol 17:a041374. https:\/\/doi.org\/10.1101\/cshperspect.a041374","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5348_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30:492\u2013506. https:\/\/doi.org\/10.1038\/s41422-020-0332-7","journal-title":"Cell Res"},{"key":"5348_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065184","volume":"8","author":"T Fiorini","year":"2013","unstructured":"Fiorini T, Koudriavtseva E, Bucaj E et al (2013) Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis. PLoS ONE 8:e65184","journal-title":"PLoS ONE"},{"key":"5348_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s44197-025-00353-6","volume":"15","author":"G Khan","year":"2025","unstructured":"Khan G, Hashim MJ (2025) Epidemiology of multiple sclerosis: global, regional, national and sub-national-level estimates and future projections. J Epidemiol Glob Health 15:21. https:\/\/doi.org\/10.1007\/s44197-025-00353-6","journal-title":"J Epidemiol Glob Health"},{"key":"5348_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/imm.13004","volume":"156","author":"MC Ysrraelit","year":"2019","unstructured":"Ysrraelit MC, Correale J (2019) Impact of sex hormones on immune function and multiple sclerosis development. Immunology 156:9\u201322. https:\/\/doi.org\/10.1111\/imm.13004","journal-title":"Immunology"},{"issue":"Suppl 1","key":"5348_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00415-008-1002-8","volume":"255","author":"HL Weiner","year":"2008","unstructured":"Weiner HL (2008) A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol 255(Suppl 1):3\u201311","journal-title":"J Neurol"},{"key":"5348_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000382130","volume":"44","author":"T Kalincik","year":"2015","unstructured":"Kalincik T (2015) Multiple sclerosis relapses: epidemiology, outcomes and management. A systematic review. Neuroepidemiology 44:199\u2013214","journal-title":"Neuroepidemiology"},{"key":"5348_CR11","doi-asserted-by":"publisher","first-page":"10323","DOI":"10.3390\/ijms221910323","volume":"22","author":"D Mathur","year":"2021","unstructured":"Mathur D, Mishra BK, Rout S, Lopez-Iranzo FJ, Lopez-Rodas G, Vallamkondu J et al (2021) Potential biomarkers associated with multiple sclerosis pathology. Int J Mol Sci 22:10323","journal-title":"Int J Mol Sci"},{"key":"5348_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029058","volume":"9","author":"A Paul","year":"2019","unstructured":"Paul A, Comabella M, Gandhi R (2019) Biomarkers in multiple sclerosis. Cold Spring Harb Perspect Med 9:a029058","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5348_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22074\/cellj.2016.4867","volume":"19","author":"N Ghasemi","year":"2017","unstructured":"Ghasemi N (2017) Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J 19:1\u201310. https:\/\/doi.org\/10.22074\/cellj.2016.4867","journal-title":"Cell J"},{"key":"5348_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010474","volume":"23","author":"IB Shalom","year":"2022","unstructured":"Shalom IB, Karni A, Kolb H (2022) The role of molecular imaging as a marker of remyelination and repair in multiple sclerosis. Int J Mol Sci 23:474","journal-title":"Int J Mol Sci"},{"key":"5348_CR15","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140:918\u2013934","journal-title":"Cell"},{"key":"5348_CR16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","volume":"8","author":"H Lassmann","year":"2012","unstructured":"Lassmann H, van Horssen J, Mahad D (2012) Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol 8:647\u2013656","journal-title":"Nat Rev Neurol"},{"key":"5348_CR17","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","volume":"365","author":"CF Lucchinetti","year":"2011","unstructured":"Lucchinetti CF, Popescu BF, Bunyan RF et al (2011) Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 365:2188\u20132197","journal-title":"N Engl J Med"},{"key":"5348_CR18","doi-asserted-by":"publisher","first-page":"1254586","DOI":"10.3389\/fimmu.2023.1254586","volume":"14","author":"P Mora","year":"2023","unstructured":"Mora P, Chapouly C (2023) Astrogliosis in multiple sclerosis and neuro-inflammation: What role for the notch pathway? Front Immunol 14:1254586. https:\/\/doi.org\/10.3389\/fimmu.2023.1254586","journal-title":"Front Immunol"},{"key":"5348_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1056\/NEJM199801293380502","volume":"338","author":"BD Trapp","year":"1998","unstructured":"Trapp BD, Peterson J, Ransohoff RM et al (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278\u2013285. https:\/\/doi.org\/10.1056\/NEJM199801293380502","journal-title":"N Engl J Med"},{"key":"5348_CR20","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/1873-3468.12972","volume":"592","author":"GR Campbell","year":"2018","unstructured":"Campbell GR, Mahad DJ (2018) Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis. FEBS Lett 592:1113\u20131121. https:\/\/doi.org\/10.1002\/1873-3468.12972","journal-title":"FEBS Lett"},{"key":"5348_CR21","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1212\/01.wnl.0000237551.26858.39","volume":"67","author":"C Wegner","year":"2006","unstructured":"Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM (2006) Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 67:960\u2013967. https:\/\/doi.org\/10.1212\/01.wnl.0000237551.26858.39","journal-title":"Neurology"},{"key":"5348_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrn3900","volume":"16","author":"M Calabrese","year":"2015","unstructured":"Calabrese M, Magliozzi R, Ciccarelli O, Geurts JJ, Reynolds R, Martin R (2015) Exploring the origins of grey matter damage in multiple sclerosis. Nat Rev Neurosci 16:147\u2013158. https:\/\/doi.org\/10.1038\/nrn3900","journal-title":"Nat Rev Neurosci"},{"key":"5348_CR23","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/brain\/awv398","volume":"139","author":"L Haider","year":"2016","unstructured":"Haider L, Zrzavy T, Hametner S, H\u00f6ftberger R, Bagnato F, Grabner G et al (2016) The topography of demyelination and neurodegeneration in the multiple sclerosis brain. Brain 139:807\u2013815. https:\/\/doi.org\/10.1093\/brain\/awv398","journal-title":"Brain"},{"key":"5348_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/neuroglia6010006","volume":"6","author":"AV Arredondo-Robles","year":"2025","unstructured":"Arredondo-Robles AV, Rodr\u00edguez-L\u00f3pez KP, \u00c1vila-Avil\u00e9s RD (2025) Clinical management in multiple sclerosis. Neuroglia 6:6. https:\/\/doi.org\/10.3390\/neuroglia6010006","journal-title":"Neuroglia"},{"key":"5348_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2377-12-11","volume":"12","author":"BFG Popescu","year":"2012","unstructured":"Popescu BFG, Lucchinetti CF (2012) Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol 12:11","journal-title":"BMC Neurol"},{"key":"5348_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fimmu.2019.00201","volume":"10","author":"S H\u00e4usser-Kinzel","year":"2019","unstructured":"H\u00e4usser-Kinzel S, Weber MS (2019) The role of B cells and antibodies in multiple sclerosis, neuromyelitis optica, and related disorders. Front Immunol 10:201","journal-title":"Front Immunol"},{"key":"5348_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/brainsci7070078","volume":"7","author":"N Dargahi","year":"2017","unstructured":"Dargahi N, Katsara M, Tselios T, Androutsou ME, de Courten M, Matsoukas J, Apostolopoulos V (2017) Multiple sclerosis: immunopathology and treatment update. Brain Sci 7:78","journal-title":"Brain Sci"},{"key":"5348_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.msard.2017.12.015","volume":"20","author":"MH Harirchian","year":"2017","unstructured":"Harirchian MH, Fatehi F, Sarraf P, Honarvar NM, Bitarafan S (2017) Worldwide prevalence of familial multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord 20:43\u201347","journal-title":"Mult Scler Relat Disord"},{"key":"5348_CR29","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1212\/CON.0000000000000725","volume":"25","author":"B Nourbakhsh","year":"2019","unstructured":"Nourbakhsh B, Mowry EM (2019) Multiple sclerosis risk factors and pathogenesis. Continuum (Minneap Minn) 25:596\u2013610","journal-title":"Continuum (Minneap Minn)"},{"key":"5348_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G (2019) Multiple sclerosis \u2013 a review. Eur J Neurol 26:27\u201340","journal-title":"Eur J Neurol"},{"key":"5348_CR31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","volume":"9","author":"SV Ramagopalan","year":"2010","unstructured":"Ramagopalan SV, Dobson R, Meier UC, Giovannoni G (2010) Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 9:727\u2013739","journal-title":"Lancet Neurol"},{"key":"5348_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0301-0082(95)80008-V","volume":"47","author":"CR Gale","year":"1995","unstructured":"Gale CR, Martyn CN (1995) Migrant studies in multiple sclerosis. Prog Neurobiol 47:425\u2013448","journal-title":"Prog Neurobiol"},{"key":"5348_CR33","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","volume":"296","author":"KL Munger","year":"2006","unstructured":"Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296:2832\u20132838","journal-title":"JAMA"},{"key":"5348_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2217\/nmt.15.33","volume":"5","author":"RM Lucas","year":"2015","unstructured":"Lucas RM, Byrne SN, Correale J, Ilschner S, Hart PH (2015) Ultraviolet radiation, vitamin D and multiple sclerosis. Neurodegener Dis Manag 5:413\u2013424","journal-title":"Neurodegener Dis Manag"},{"key":"5348_CR35","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.20906.1","volume":"8","author":"PK Stys","year":"2019","unstructured":"Stys PK, Tsutsui S (2019) Recent advances in understanding multiple sclerosis. F1000Res 8:2100. https:\/\/doi.org\/10.12688\/f1000research.20906.1","journal-title":"F1000Res"},{"key":"5348_CR36","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/medicina61040730","volume":"61","author":"M Alruwaili","year":"2025","unstructured":"Alruwaili M, Basri R (2025) Environmental and familial risk factors for multiple sclerosis: insights from a Saudi Arabian cohort. Medicina (Kaunas) 61:730. https:\/\/doi.org\/10.3390\/medicina61040730","journal-title":"Medicina (Kaunas)"},{"key":"5348_CR37","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/jnnp.2011.240432","volume":"82","author":"S Simpson Jr","year":"2011","unstructured":"Simpson S Jr, Blizzard L, Otahal P, Van der Mei I, Taylor B (2011) Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 82:1132\u20131141","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5348_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clinbiochem.2011.09.021","volume":"45","author":"E Miller","year":"2012","unstructured":"Miller E, Walczak A, Saluk J, Ponczek MB, Majsterek I (2012) Oxidative modification of patient\u2019s plasma proteins and its role in pathogenesis of multiple sclerosis. Clin Biochem 45:26\u201330","journal-title":"Clin Biochem"},{"key":"5348_CR39","doi-asserted-by":"publisher","first-page":"20037","DOI":"10.3390\/ijms141020037","volume":"14","author":"M Tully","year":"2013","unstructured":"Tully M, Shi R (2013) New insights in the pathogenesis of multiple sclerosis\u2013role of acrolein in neuronal and myelin damage. Int J Mol Sci 14:20037\u201320047","journal-title":"Int J Mol Sci"},{"key":"5348_CR40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12974-015-0375-8","volume":"12","author":"O Errea","year":"2015","unstructured":"Errea O, Moreno B, Gonzalez-Franquesa A, Garcia-Roves PM, Villoslada P (2015) The disruption of mitochondrial axonal transport is an early event in neuroinflammation. J Neuroinflammation 12:152","journal-title":"J Neuroinflammation"},{"key":"5348_CR41","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1177\/1352458513498128","volume":"20","author":"S Rossi","year":"2014","unstructured":"Rossi S, Motta C, Studer V et al (2014) Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration. Mult Scler 20:304\u2013312","journal-title":"Mult Scler"},{"key":"5348_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/archneur.63.1.25","volume":"63","author":"J Imitola","year":"2006","unstructured":"Imitola J, Chitnis T, Khoury SJ (2006) Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapies. Arch Neurol 63:25\u201333","journal-title":"Arch Neurol"},{"key":"5348_CR43","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/gene.2016.23","volume":"17","author":"JP Hussman","year":"2016","unstructured":"Hussman JP, Beecham AH, Schmidt M et al (2016) GWAS analysis implicates NF-\u03baB mediated induction of inflammatory T cells in multiple sclerosis. Genes Immun 17:305\u2013312","journal-title":"Genes Immun"},{"key":"5348_CR44","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L et al (2020) Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS, third edition. Mult Scler 26:1816\u20131821. https:\/\/doi.org\/10.1177\/1352458520970841","journal-title":"Mult Scler"},{"key":"5348_CR45","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3111\/13696998.2013.778268","volume":"16","author":"G Adelman","year":"2013","unstructured":"Adelman G, Rane SG, Villa KF (2013) The cost burden of multiple sclerosis in the United States: a systematic review of the literature. J Med Econ 16:639\u2013647","journal-title":"J Med Econ"},{"key":"5348_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.574133","volume":"7","author":"L Porter","year":"2020","unstructured":"Porter L, Shoushtarizadeh A, Jelinek GA et al (2020) Metabolomic biomarkers of multiple sclerosis: a systematic review. Front Mol Biosci 7:574133","journal-title":"Front Mol Biosci"},{"key":"5348_CR47","first-page":"14","volume":"8","author":"S Toscano","year":"2021","unstructured":"Toscano S, Patti F (2021) CSF biomarkers in multiple sclerosis: beyond neuroinflammation. Neuroimmunol Neuroinflamm 8:14\u201341","journal-title":"Neuroimmunol Neuroinflamm"},{"key":"5348_CR48","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s40291-014-0117-0","volume":"18","author":"VK Harris","year":"2014","unstructured":"Harris VK, Sadiq SA (2014) Biomarkers of therapeutic response in multiple sclerosis: current status. Mol Diagn Ther 18:605\u2013617. https:\/\/doi.org\/10.1007\/s40291-014-0117-0","journal-title":"Mol Diagn Ther"},{"key":"5348_CR49","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7861\/clinmed.2020-0292","volume":"20","author":"H Ford","year":"2020","unstructured":"Ford H (2020) Clinical presentation and diagnosis of multiple sclerosis. Clin Med (Lond) 20:380\u2013383. https:\/\/doi.org\/10.7861\/clinmed.2020-0292","journal-title":"Clin Med (Lond)"},{"key":"5348_CR50","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1093\/brain\/awv105","volume":"138","author":"M Tintore","year":"2015","unstructured":"Tintore M, Rovira \u00c0, R\u00edo J et al (2015) Defining high, medium, and low impact prognostic factors for developing multiple sclerosis. Brain 138:1863\u20131874","journal-title":"Brain"},{"key":"5348_CR51","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/1352458507082046","volume":"14","author":"L Villar","year":"2008","unstructured":"Villar L, Garc\u00eda-Barrag\u00e1n N, Espi\u00f1o M et al (2008) Influence of oligoclonal IgM specificity in multiple sclerosis disease course. Mult Scler 14:183\u2013187","journal-title":"Mult Scler"},{"key":"5348_CR52","doi-asserted-by":"publisher","DOI":"10.3410\/M5-4","volume":"5","author":"JA Brebner","year":"2013","unstructured":"Brebner JA, Stockley RA (2013) Polyclonal free light chains: a biomarker of inflammatory disease or treatment target? F1000 Med Rep 5:4","journal-title":"F1000 Med Rep"},{"key":"5348_CR53","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/bpa.12084","volume":"23","author":"S Jarius","year":"2013","unstructured":"Jarius S, Wildemann B (2013) Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol 23:661\u2013683. https:\/\/doi.org\/10.1111\/bpa.12084","journal-title":"Brain Pathol"},{"key":"5348_CR54","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/s41433-017-0010-2","volume":"32","author":"J Britze","year":"2018","unstructured":"Britze J, Frederiksen JL (2018) Optical coherence tomography in multiple sclerosis. Eye (Lond) 32:884\u2013888","journal-title":"Eye (Lond)"},{"key":"5348_CR55","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jceh.2015.10.006","volume":"5","author":"JM Tognarelli","year":"2015","unstructured":"Tognarelli JM, Dawood M, Shariff MIF et al (2015) Magnetic resonance spectroscopy: principles and techniques\u2014lessons for clinicians. J Clin Exp Hepatol 5:320","journal-title":"J Clin Exp Hepatol"},{"key":"5348_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109610","volume":"137","author":"J Arm","year":"2021","unstructured":"Arm J, Oeltzschner G, Al-iedani O et al (2021) Altered in vivo brain GABA and glutamate levels are associated with multiple sclerosis central fatigue. Eur J Radiol 137:109610","journal-title":"Eur J Radiol"},{"key":"5348_CR57","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3389\/fnins.2020.566643","volume":"14","author":"OM Gonen","year":"2020","unstructured":"Gonen OM, Moffat BA, Kwan P et al (2020) Reproducibility of glutamate, glutathione, and GABA measurements in vivo by single-voxel STEAM magnetic resonance spectroscopy at 7-Tesla in healthy individuals. Front Neurosci 14:968","journal-title":"Front Neurosci"},{"key":"5348_CR58","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1212\/01.wnl.0000238107.31364.21","volume":"67","author":"JR Rinker 2nd","year":"2006","unstructured":"Rinker JR 2nd, Trinkaus K, Cross AH (2006) Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis. Neurology 67:1288\u20131290","journal-title":"Neurology"},{"key":"5348_CR59","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1177\/1352458516634422","volume":"22","author":"J Kuhle","year":"2016","unstructured":"Kuhle J, Barro C, Disanto G et al (2016) Serum neurofilament light chain in early relapsing\u2013remitting MS is increased and correlates with CSF levels and MRI measures of disease severity. Mult Scler 22:1550\u20131559. https:\/\/doi.org\/10.1177\/1352458516634422","journal-title":"Mult Scler"},{"key":"5348_CR60","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s00415-010-5855-8","volume":"258","author":"M Axelsson","year":"2011","unstructured":"Axelsson M, Malmestr\u00f6m C, Nilsson S et al (2011) Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis. J Neurol 258:882\u2013888. https:\/\/doi.org\/10.1007\/s00415-010-5855-8","journal-title":"J Neurol"},{"key":"5348_CR61","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1001\/jamaneurol.2018.3655","volume":"76","author":"E Canto","year":"2019","unstructured":"Canto E, Barro C, Zhao C et al (2019) Association between CSF chitinase-3-like-1 levels and long-term disability progression in multiple sclerosis. JAMA Neurol 76:210\u2013219. https:\/\/doi.org\/10.1001\/jamaneurol.2018.3655","journal-title":"JAMA Neurol"},{"key":"5348_CR62","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ana.20202","volume":"56","author":"K Schmierer","year":"2004","unstructured":"Schmierer K, Scaravilli F, Altmann DR et al (2004) Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 56:407\u2013415. https:\/\/doi.org\/10.1002\/ana.20202","journal-title":"Ann Neurol"},{"key":"5348_CR63","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1093\/brain\/awx228","volume":"140","author":"G Datta","year":"2017","unstructured":"Datta G, Colasanti A, Rabiner EA et al (2017) Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis. Brain 140:2927\u20132938. https:\/\/doi.org\/10.1093\/brain\/awx228","journal-title":"Brain"},{"key":"5348_CR64","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1073\/pnas.1711235114","volume":"114","author":"E Cekanaviciute","year":"2017","unstructured":"Cekanaviciute E, Yoo BB, Runia TF et al (2017) Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci USA 114:10713\u201310718. https:\/\/doi.org\/10.1073\/pnas.1711235114","journal-title":"Proc Natl Acad Sci USA"},{"key":"5348_CR65","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ana.24954","volume":"81","author":"G Disanto","year":"2017","unstructured":"Disanto G, Barro C, Benkert P et al (2017) Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis. Ann Neurol 81:857\u2013870. https:\/\/doi.org\/10.1002\/ana.24954","journal-title":"Ann Neurol"},{"key":"5348_CR66","doi-asserted-by":"publisher","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","volume":"365","author":"IMSGC","year":"2019","unstructured":"IMSGC (2019) Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365:eaav7188. https:\/\/doi.org\/10.1126\/science.aav7188","journal-title":"Science"},{"key":"5348_CR67","doi-asserted-by":"publisher","first-page":"10719","DOI":"10.1073\/pnas.1711233114","volume":"114","author":"K Berer","year":"2017","unstructured":"Berer K, Gerdes LA, Cekanaviciute E et al (2017) Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci USA 114:10719\u201310724. https:\/\/doi.org\/10.1073\/pnas.1711233114","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"5348_CR68","first-page":"S17","volume":"74","author":"S Dhib-Jalbut","year":"2010","unstructured":"Dhib-Jalbut S, Marks S (2010) Interferon-beta mechanisms of action in multiple sclerosis. Neurology 74(Suppl 1):S17\u2013S24","journal-title":"Neurology"},{"key":"5348_CR69","first-page":"117","volume":"4","author":"C Warnke","year":"2010","unstructured":"Warnke C, Wiendl H, Hartung HP et al (2010) Identification of targets and new developments in the treatment of multiple sclerosis\u2013focus on cladribine. Drug Des Devel Ther 4:117\u2013126","journal-title":"Drug Des Devel Ther"},{"key":"5348_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577721","volume":"360","author":"S Sriwastava","year":"2021","unstructured":"Sriwastava S, Kataria S, Srivastava S et al (2021) Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: a systematic review and meta-analysis. J Neuroimmunol 360:577721. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577721","journal-title":"J Neuroimmunol"},{"key":"5348_CR71","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.dhjo.2014.05.004","volume":"7","author":"M Vitkova","year":"2014","unstructured":"Vitkova M, Gdovinova Z, Rosenberger J et al (2014) Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration. Disabil Health J 7:466\u2013471","journal-title":"Disabil Health J"},{"key":"5348_CR72","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s40263-022-00939-9","volume":"36","author":"S Faissner","year":"2022","unstructured":"Faissner S, Gold R (2022) Efficacy and safety of multiple sclerosis drugs approved since 2018 and future developments. CNS Drugs 36:803\u2013817. https:\/\/doi.org\/10.1007\/s40263-022-00939-9","journal-title":"CNS Drugs"},{"issue":"Suppl 3","key":"5348_CR73","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.12968\/bjnn.2022.18.Sup3.S16","volume":"18","author":"J Harrison","year":"2022","unstructured":"Harrison J, Hill J, Palmer K (2022) Disease modifying therapies for multiple sclerosis: benefit and acceptability. Br J Neurosci Nurs 18(Suppl 3):S16\u2013S19. https:\/\/doi.org\/10.12968\/bjnn.2022.18.Sup3.S16","journal-title":"Br J Neurosci Nurs"},{"key":"5348_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2025.e00601","volume":"22","author":"M Albelo-Mart\u00ednez","year":"2025","unstructured":"Albelo-Mart\u00ednez M, Rizvi S (2025) Progressive multiple sclerosis: evaluating current therapies and exploring future treatment strategies. Neurotherapeutics 22:e00601. https:\/\/doi.org\/10.1016\/j.neurot.2025.e00601","journal-title":"Neurotherapeutics"},{"key":"5348_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1176016","volume":"14","author":"M Bronzini","year":"2023","unstructured":"Bronzini M, Maglione A, Rosso R, Matta M, Masuzzo F, Rolla S et al (2023) Feeding the gut microbiome: impact on multiple sclerosis. Front Immunol 14:1176016. https:\/\/doi.org\/10.3389\/fimmu.2023.1176016","journal-title":"Front Immunol"},{"key":"5348_CR76","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1007\/s12035-025-04728-5","volume":"62","author":"E Mohsen","year":"2025","unstructured":"Mohsen E, Haffez H, Ahmed S et al (2025) Multiple sclerosis: a story of the interaction between gut microbiome and components of the immune system. Mol Neurobiol 62:7762\u20137775. https:\/\/doi.org\/10.1007\/s12035-025-04728-5","journal-title":"Mol Neurobiol"},{"key":"5348_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101982","volume":"6","author":"KJ O\u2019Riordan","year":"2025","unstructured":"O\u2019Riordan KJ, Moloney GM, Keane L, Clarke G, Cryan JF (2025) The gut microbiota-immune-brain axis: therapeutic implications. Cell Rep Med 6:101982. https:\/\/doi.org\/10.1016\/j.xcrm.2025.101982","journal-title":"Cell Rep Med"},{"key":"5348_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60010006","volume":"60","author":"I Del Negro","year":"2024","unstructured":"Del Negro I, Pez S, Versace S, Marziali A, Gigli GL, Tereshko Y, Valente M (2024) Impact of disease-modifying therapies on gut-brain axis in multiple sclerosis. Medicina (B Aires) 60:6","journal-title":"Medicina (B Aires)"},{"key":"5348_CR79","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.83386","volume":"17","author":"F Saleem","year":"2025","unstructured":"Saleem F, Shadia S, Govindasamy V, Fatima R, Khan RM, Suresh KN et al (2025) Association between gastrointestinal symptoms and disease severity in multiple sclerosis patients. Cureus 17:e83386. https:\/\/doi.org\/10.7759\/cureus.83386","journal-title":"Cureus"},{"key":"5348_CR80","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/DNND.S138835","volume":"8","author":"G Preziosi","year":"2018","unstructured":"Preziosi G, Gordon-Dixon A, Emmanuel A (2018) Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategies. Degener Neurol Neuromuscul Dis 8:79\u201390. https:\/\/doi.org\/10.2147\/DNND.S138835","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"5348_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6030069","volume":"6","author":"TO Kirby","year":"2018","unstructured":"Kirby TO, Ochoa-Rep\u00e1raz J (2018) The gut microbiome in multiple sclerosis: a potential therapeutic avenue. Med Sci (Basel) 6:69. https:\/\/doi.org\/10.3390\/medsci6030069","journal-title":"Med Sci (Basel)"},{"key":"5348_CR82","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan Y, Pedersen O (2021) Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 19:55\u201371. https:\/\/doi.org\/10.1038\/s41579-020-0433-9","journal-title":"Nat Rev Microbiol"},{"key":"5348_CR83","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/biom11050678","volume":"11","author":"VK Sharma","year":"2021","unstructured":"Sharma VK, Singh TG, Garg N, Dhiman S, Gupta S, Rahman H et al (2021) Dysbiosis and Alzheimer\u2019s disease: a role for chronic stress? Biomolecules 11:678","journal-title":"Biomolecules"},{"key":"5348_CR84","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s00415-023-12107-0","volume":"271","author":"CC Tsai","year":"2024","unstructured":"Tsai CC, Jette S, Tremlett H (2024) Disease-modifying therapies used to treat multiple sclerosis and the gut microbiome: a systematic review. J Neurol 271:1108\u20131123. https:\/\/doi.org\/10.1007\/s00415-023-12107-0","journal-title":"J Neurol"},{"key":"5348_CR85","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/medsci6040069","volume":"6","author":"TO Kirby","year":"2018","unstructured":"Kirby TO, Ochoa-Rep\u00e1raz J (2018) The gut microbiome in multiple sclerosis: a potential therapeutic avenue. Med Sci (Basel) 6:69. https:\/\/doi.org\/10.3390\/medsci6040069","journal-title":"Med Sci (Basel)"},{"key":"5348_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/srep28484","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen J, Chia N, Kalari KR, Yao JZ, Novotna M et al (2016) Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep 6:28484","journal-title":"Sci Rep"},{"key":"5348_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01390","volume":"11","author":"M Saresella","year":"2020","unstructured":"Saresella M, Marventano I, Barone M, La Rosa F, Piancone F, Mendozzi L et al (2020) Alterations in circulating fatty acid are associated with gut microbiota dysbiosis and inflammation in multiple sclerosis. Front Immunol 11:1390","journal-title":"Front Immunol"},{"key":"5348_CR88","doi-asserted-by":"publisher","first-page":"10719","DOI":"10.1073\/pnas.1711233114","volume":"114","author":"K Berer","year":"2017","unstructured":"Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L, Xia Z et al (2017) Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci USA 114:10719\u201310724","journal-title":"Proc Natl Acad Sci USA"},{"key":"5348_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00442","volume":"21","author":"N Kawakami","year":"2024","unstructured":"Kawakami N, Wekerle H (2024) Life history of a brain autoreactive T cell: from thymus through intestine to blood-brain barrier and brain lesion. Neurotherapeutics 21:e00442. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00442","journal-title":"Neurotherapeutics"},{"key":"5348_CR90","doi-asserted-by":"publisher","first-page":"1101379","DOI":"10.3389\/fncel.2023.1101379","volume":"17","author":"G Angelini","year":"2023","unstructured":"Angelini G, Bani A, Constantin G, Rossi B (2023) The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis. Front Cell Neurosci 17:1101379. https:\/\/doi.org\/10.3389\/fncel.2023.1101379","journal-title":"Front Cell Neurosci"},{"key":"5348_CR91","doi-asserted-by":"publisher","first-page":"2387794","DOI":"10.1080\/19490976.2024.2387794","volume":"16","author":"TA Turner","year":"2024","unstructured":"Turner TA, Lehman P, Ghimire S, Shahi SK, Mangalam A (2024) Game of microbes: the battle within - gut microbiota and multiple sclerosis. Gut Microbes 16:2387794. https:\/\/doi.org\/10.1080\/19490976.2024.2387794","journal-title":"Gut Microbes"},{"key":"5348_CR92","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1352458517737372","volume":"24","author":"S Haase","year":"2018","unstructured":"Haase S, Haghikia A, Gold R, Linker RA (2018) Dietary fatty acids and susceptibility to multiple sclerosis. Mult Scler 24:12\u201316. https:\/\/doi.org\/10.1177\/1352458517737372","journal-title":"Mult Scler"},{"issue":"0","key":"5348_CR93","volume":"26","author":"JM Rodriguez","year":"2015","unstructured":"Rodriguez JM, Murphy K, Stanton C et al (2015) The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis 26(0):26050","journal-title":"Microb Ecol Health Dis"},{"key":"5348_CR94","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/gutjnl-2012-302167","volume":"62","author":"M Simren","year":"2013","unstructured":"Simren M, Barbara G, Flint HJ et al (2013) Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 62:159\u2013176","journal-title":"Gut"},{"key":"5348_CR95","doi-asserted-by":"publisher","first-page":"1130689","DOI":"10.3389\/fendo.2023.1130689","volume":"14","author":"JA Rusch","year":"2023","unstructured":"Rusch JA, Layden BT, Dugas LR (2023) Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis. Front Endocrinol (Lausanne) 14:1130689. https:\/\/doi.org\/10.3389\/fendo.2023.1130689","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5348_CR96","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/brainsci13081226","volume":"13","author":"T Benameur","year":"2023","unstructured":"Benameur T, Porro C, Twfieg ME, Benameur N, Panaro MA, Filannino FM et al (2023) Emerging paradigms in inflammatory disease management: exploring bioactive compounds and the gut microbiota. Brain Sci 13:1226. https:\/\/doi.org\/10.3390\/brainsci13081226","journal-title":"Brain Sci"},{"key":"5348_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137429","volume":"10","author":"S Miyake","year":"2015","unstructured":"Miyake S, Kim S, Suda W et al (2015) Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters. PLoS ONE 10:e0137429. https:\/\/doi.org\/10.1371\/journal.pone.0137429","journal-title":"PLoS ONE"},{"key":"5348_CR98","doi-asserted-by":"publisher","first-page":"e2175","DOI":"10.1212\/WNL.0000000000008588","volume":"93","author":"I Katz Sand","year":"2019","unstructured":"Katz Sand I, Zhu Y, Ntranos A et al (2019) Disease-modifying effect of dietary intervention in multiple sclerosis: a randomized clinical trial. Neurology 93:e2175\u2013e2186. https:\/\/doi.org\/10.1212\/WNL.0000000000008588","journal-title":"Neurology"},{"key":"5348_CR99","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s13311-015-0333-5","volume":"12","author":"P Riccio","year":"2015","unstructured":"Riccio P, Rossano R (2015) Diet, gut microbiota, and vitamins D + A in multiple sclerosis. Neurotherapeutics 12:317\u2013325. https:\/\/doi.org\/10.1007\/s13311-015-0333-5","journal-title":"Neurotherapeutics"},{"key":"5348_CR100","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4161\/gmic.19320","volume":"3","author":"HJ Wu","year":"2012","unstructured":"Wu HJ, Wu E (2012) The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 3:4\u201314. https:\/\/doi.org\/10.4161\/gmic.19320","journal-title":"Gut Microbes"},{"key":"5348_CR101","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.it.2024.01.006","volume":"45","author":"M Bemark","year":"2024","unstructured":"Bemark M, Pitcher MJ, Dionisi C, Spencer J (2024) Gut-associated lymphoid tissue: a microbiota-driven hub of B cell immunity. Trends Immunol 45:211\u2013223. https:\/\/doi.org\/10.1016\/j.it.2024.01.006","journal-title":"Trends Immunol"},{"key":"5348_CR102","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","volume":"122","author":"AP Robinson","year":"2014","unstructured":"Robinson AP, Harp CT, Noronha A, Miller SD (2014) The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol 122:173\u2013189. https:\/\/doi.org\/10.1016\/B978-0-444-52001-2.00008-X","journal-title":"Handb Clin Neurol"},{"key":"5348_CR103","doi-asserted-by":"publisher","first-page":"51275","DOI":"10.3791\/51275","volume":"86","author":"S Bittner","year":"2014","unstructured":"Bittner S, Afzali AM, Wiendl H, Meuth SG (2014) Myelin oligodendrocyte glycoprotein (MOG35\u201355) induced experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice. J Vis Exp 86:51275. https:\/\/doi.org\/10.3791\/51275","journal-title":"J Vis Exp"},{"key":"5348_CR104","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164:1079\u20131106. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01302.x","journal-title":"Br J Pharmacol"},{"key":"5348_CR105","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","volume":"133","author":"H Lassmann","year":"2017","unstructured":"Lassmann H, Bradl M (2017) Multiple sclerosis: experimental models and reality. Acta Neuropathol 133:223\u2013244. https:\/\/doi.org\/10.1007\/s00401-016-1631-4","journal-title":"Acta Neuropathol"},{"key":"5348_CR106","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3390\/cells12050793","volume":"12","author":"J Wang","year":"2023","unstructured":"Wang J, Zhu N, Su X, Gao Y, Yang R (2023) Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis. Cells 12:793. https:\/\/doi.org\/10.3390\/cells12050793","journal-title":"Cells"},{"key":"5348_CR107","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200355","volume":"12","author":"VK Gupta","year":"2025","unstructured":"Gupta VK, Janda GS, Pump HK, Lele N, Cruz I, Cohen I et al (2025) Alterations in gut microbiome-host relationships after immune perturbation in patients with multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 12:e200355. https:\/\/doi.org\/10.1212\/NXI.0000000000200355","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"5348_CR108","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/jamapsychiatry.2021.2573","volume":"78","author":"VL Nikolova","year":"2021","unstructured":"Nikolova VL, Hall M, Hall L et al (2021) Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis. JAMA Psychiatr 78:1343\u20131354","journal-title":"JAMA Psychiatr"},{"key":"5348_CR109","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3945\/jn.116.240481","volume":"147","author":"M van de Wouw","year":"2017","unstructured":"van de Wouw M, Schellekens H, Dinan TG, Cryan JF (2017) Microbiota-gut-brain axis: modulator of host metabolism and appetite. J Nutr 147:727\u2013745","journal-title":"J Nutr"},{"key":"5348_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102055","volume":"6","author":"LA Schwerdtfeger","year":"2025","unstructured":"Schwerdtfeger LA, Montini F, Lanser TB, Ekwudo MN, Zurawski J, Tauhid S et al (2025) Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med 6:102055. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102055","journal-title":"Cell Rep Med"},{"key":"5348_CR111","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12974-022-02502-1","volume":"19","author":"H Yu","year":"2022","unstructured":"Yu H, Bai S, Hao Y et al (2022) Fatty acids role in multiple sclerosis as \u2018metabokines.\u2019 J Neuroinflammation 19:157. https:\/\/doi.org\/10.1186\/s12974-022-02502-1","journal-title":"J Neuroinflammation"},{"key":"5348_CR112","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s13679-023-00503-6","volume":"12","author":"O Lange","year":"2023","unstructured":"Lange O, Proczko-Stepaniak M, Mika A (2023) Short-chain fatty acids\u2014a product of the microbiome and its participation in two-way communication on the microbiome-host mammal line. Curr Obes Rep 12:108\u2013126. https:\/\/doi.org\/10.1007\/s13679-023-00503-6","journal-title":"Curr Obes Rep"},{"key":"5348_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.668330","volume":"12","author":"MA Hidalgo","year":"2021","unstructured":"Hidalgo MA, Carretta MD, Burgos RA (2021) Long chain fatty acids as modulators of immune cells function: contribution of FFA1 and FFA4 receptors. Front Physiol 12:668330. https:\/\/doi.org\/10.3389\/fphys.2021.668330","journal-title":"Front Physiol"},{"key":"5348_CR114","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/biom10081127","volume":"10","author":"VS Shramko","year":"2020","unstructured":"Shramko VS, Polonskaya YV, Kashtanova EV, Stakhneva EM, Ragino YI (2020) The short overview on the relevance of fatty acids for human cardiovascular disorders. Biomolecules 10:1127. https:\/\/doi.org\/10.3390\/biom10081127","journal-title":"Biomolecules"},{"key":"5348_CR115","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.3390\/nu15204466","volume":"15","author":"Y Shin","year":"2023","unstructured":"Shin Y, Han S, Kwon J, Ju S, Choi TG, Kang I et al (2023) Roles of short-chain fatty acids in inflammatory bowel disease. Nutrients 15:4466. https:\/\/doi.org\/10.3390\/nu15204466","journal-title":"Nutrients"},{"key":"5348_CR116","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/cells12131760","volume":"12","author":"A Dunalska","year":"2023","unstructured":"Dunalska A, Saramak K, Szejko N (2023) The role of gut microbiome in the pathogenesis of multiple sclerosis and related disorders. Cells 12:1760. https:\/\/doi.org\/10.3390\/cells12131760","journal-title":"Cells"},{"key":"5348_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2024.106870","volume":"129","author":"U Choe","year":"2025","unstructured":"Choe U (2025) Role of dietary fiber and short-chain fatty acids in preventing neurodegenerative diseases through the gut-brain axis. J Funct Foods 129:106870. https:\/\/doi.org\/10.1016\/j.jff.2024.106870","journal-title":"J Funct Foods"},{"key":"5348_CR118","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2020.00025","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne) 11:25","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"16 Suppl","key":"5348_CR119","doi-asserted-by":"publisher","first-page":"P1.374","DOI":"10.1212\/WNL.86.16_supplement.P1.374","volume":"86","author":"A Haghikia","year":"2016","unstructured":"Haghikia A, Duscha A, Berg J, J\u00f6rg S, Wilck N, M\u00fcller D et al (2016) Role of fatty acids in multiple sclerosis: therapeutic potential of propionic acid (P1.374). Neurology 86(16 Suppl):P1.374","journal-title":"Neurology"},{"key":"5348_CR120","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/nu12041107","volume":"12","author":"P Markowiak-Kope\u0107","year":"2020","unstructured":"Markowiak-Kope\u0107 P, \u015ali\u017cewska K (2020) The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients 12:1107. https:\/\/doi.org\/10.3390\/nu12041107","journal-title":"Nutrients"},{"key":"5348_CR121","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/nutraceuticals5030019","volume":"5","author":"MT Zhu","year":"2025","unstructured":"Zhu MT, Lee JWJ (2025) Therapeutic potential of short-chain fatty acids in gastrointestinal diseases. Nutraceuticals 5:19. https:\/\/doi.org\/10.3390\/nutraceuticals5030019","journal-title":"Nutraceuticals"},{"key":"5348_CR122","doi-asserted-by":"publisher","first-page":"1103836","DOI":"10.3389\/fmicb.2022.1103836","volume":"13","author":"V Singh","year":"2023","unstructured":"Singh V, Lee G, Son H, Koh H, Kim ES, Unno T et al (2023) Butyrate producers, \u2018the sentinel of gut\u2019: their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics. Front Microbiol 13:1103836. https:\/\/doi.org\/10.3389\/fmicb.2022.1103836","journal-title":"Front Microbiol"},{"key":"5348_CR123","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/ana.26084","volume":"89","author":"LM Cox","year":"2021","unstructured":"Cox LM, Maghzi AH, Liu S, Tankou SK, Dhang FH, Willocq V et al (2021) Gut microbiome in progressive multiple sclerosis. Ann Neurol 89:1195\u20131210. https:\/\/doi.org\/10.1002\/ana.26084","journal-title":"Ann Neurol"},{"key":"5348_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103293","volume":"66","author":"S Deleu","year":"2021","unstructured":"Deleu S, Machiels K, Raes J, Verbeke K, Vermeire S (2021) Short chain fatty acids and its producing organisms: an overlooked therapy for IBD? EBioMedicine 66:103293. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103293","journal-title":"EBioMedicine"},{"key":"5348_CR125","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/ane.13045","volume":"139","author":"P Melbye","year":"2019","unstructured":"Melbye P, Olsson A, Hansen TH, S\u00f8ndergaard HB, Oturai AB (2019) Short-chain fatty acids and gut microbiota in multiple sclerosis. Acta Neurol Scand 139:208\u2013219. https:\/\/doi.org\/10.1111\/ane.13045","journal-title":"Acta Neurol Scand"},{"key":"5348_CR126","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng L, Li ZR, Green RS, Holzman IR, Lin J (2009) Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 139:1619\u20131625. https:\/\/doi.org\/10.3945\/jn.109.104638","journal-title":"J Nutr"},{"key":"5348_CR127","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, Gonz\u00e1lez MJ, Quera R, Dijkstra G et al (2019) Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10:277","journal-title":"Front Immunol"},{"key":"5348_CR128","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","volume":"23","author":"K Makki","year":"2018","unstructured":"Makki K, Deehan EC, Walter J, B\u00e4ckhed F (2018) The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe 23:705\u2013715. https:\/\/doi.org\/10.1016\/j.chom.2018.05.012","journal-title":"Cell Host Microbe"},{"key":"5348_CR129","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3009759","volume":"6","author":"V Braniste","year":"2014","unstructured":"Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, T\u00f3th M et al (2014) The gut microbiota influences blood\u2013brain barrier permeability in mice. Sci Transl Med 6:263ra158. https:\/\/doi.org\/10.1126\/scitranslmed.3009759","journal-title":"Sci Transl Med"},{"key":"5348_CR130","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12974-023-02668-0","volume":"20","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liu H, Deng L, Li J, Chen D, Xu X (2023) Butyrate alleviates neuroinflammation and mitochondrial damage in EAE mice by activating the PGC-1\u03b1 signaling pathway. J Neuroinflammation 20:19. https:\/\/doi.org\/10.1186\/s12974-023-02668-0","journal-title":"J Neuroinflammation"},{"key":"5348_CR131","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/1352458516652498","volume":"23","author":"MC Buscarinu","year":"2017","unstructured":"Buscarinu MC, Cerasoli B, Annibali V, Policano C, Lionetto L, Capi M et al (2017) Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study. Mult Scler 23:442\u2013446. https:\/\/doi.org\/10.1177\/1352458516652498","journal-title":"Mult Scler"},{"key":"5348_CR132","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.4103\/1673-5374.387974","volume":"19","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang Y, Zhu M, Liu K, Zhang HL (2024) Gut flora in multiple sclerosis: implications for pathogenesis and treatment. Neural Regen Res 19:1480\u20131488. https:\/\/doi.org\/10.4103\/1673-5374.387974","journal-title":"Neural Regen Res"},{"key":"5348_CR133","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-02586-z","author":"AHS Wadan","year":"2025","unstructured":"Wadan AHS, El-Aziz MKA, Ellakwa DES (2025) The microbiota-gut-brain-axis theory: role of gut microbiota modulators (GMMs) in gastrointestinal, neurological, and mental health disorders. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-02586-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5348_CR134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173032","volume":"12","author":"M Mizuno","year":"2017","unstructured":"Mizuno M, Noto D, Kaga N, Chiba A, Miyake S (2017) The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models. PLoS ONE 12:e0173032. https:\/\/doi.org\/10.1371\/journal.pone.0173032","journal-title":"PLoS ONE"},{"key":"5348_CR135","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P et al (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504:451\u2013455. https:\/\/doi.org\/10.1038\/nature12726","journal-title":"Nature"},{"key":"5348_CR136","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446\u2013450. https:\/\/doi.org\/10.1038\/nature12721","journal-title":"Nature"},{"key":"5348_CR137","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3389\/fimmu.2017.01036","volume":"8","author":"M Kespohl","year":"2017","unstructured":"Kespohl M, Vachharajani N, Luu M, Harb H, Pautz A, Wolff MJ et al (2017) The microbial metabolite butyrate induces expression of Th1-associated factors in CD4+ T cells. Front Immunol 8:1036","journal-title":"Front Immunol"},{"key":"5348_CR138","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bbadis.2010.07.008","volume":"1812","author":"EM Chastain","year":"2011","unstructured":"Chastain EM, Duncan DS, Rodgers JM, Miller SD (2011) The role of antigen presenting cells in multiple sclerosis. Biochim Biophys Acta 1812:265\u2013274. https:\/\/doi.org\/10.1016\/j.bbadis.2010.07.008","journal-title":"Biochim Biophys Acta"},{"key":"5348_CR139","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.immuni.2016.04.006","volume":"44","author":"A Haghikia","year":"2016","unstructured":"Haghikia A, J\u00f6rg S, Duscha A, Berg J, Manzel A, Waschbisch A et al (2016) Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 44:951\u2013953. https:\/\/doi.org\/10.1016\/j.immuni.2016.04.006","journal-title":"Immunity"},{"key":"5348_CR140","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8168717","volume":"2018","author":"F Chu","year":"2018","unstructured":"Chu F, Shi M, Lang Y, Shen D, Jin T, Zhu J et al (2018) Gut microbiota in multiple sclerosis and experimental autoimmune encephalomyelitis: current applications and future perspectives. Mediators Inflamm 2018:8168717. https:\/\/doi.org\/10.1155\/2018\/8168717","journal-title":"Mediators Inflamm"},{"key":"5348_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1146748","volume":"10","author":"K Hoffman","year":"2023","unstructured":"Hoffman K, Doyle WJ, Schumacher SM, Ochoa-Rep\u00e1raz J (2023) Gut microbiome-modulated dietary strategies in EAE and multiple sclerosis. Front Nutr 10:1146748. https:\/\/doi.org\/10.3389\/fnut.2023.1146748","journal-title":"Front Nutr"},{"key":"5348_CR142","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cell.2020.02.035","volume":"180","author":"A Duscha","year":"2020","unstructured":"Duscha A, Gisevius B, Hirschberg S, Yissachar N, Stangl GI, Dawin E et al (2020) Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism. Cell 180:1067-1080.e16. https:\/\/doi.org\/10.1016\/j.cell.2020.02.035","journal-title":"Cell"},{"key":"5348_CR143","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2020.00025","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne) 11:25","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5348_CR144","doi-asserted-by":"publisher","first-page":"1145241","DOI":"10.3389\/fnagi.2023.1145241","volume":"15","author":"S Khatoon","year":"2023","unstructured":"Khatoon S, Kalam N, Rashid S, Bano G (2023) Effects of gut microbiota on neurodegenerative diseases. Front Aging Neurosci 15:1145241. https:\/\/doi.org\/10.3389\/fnagi.2023.1145241","journal-title":"Front Aging Neurosci"},{"key":"5348_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2020.103493","volume":"105","author":"TJ Wenzel","year":"2020","unstructured":"Wenzel TJ, Gates EJ, Ranger AL, Klegeris A (2020) Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells. Mol Cell Neurosci 105:103493. https:\/\/doi.org\/10.1016\/j.mcn.2020.103493","journal-title":"Mol Cell Neurosci"},{"key":"5348_CR146","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1973834","volume":"2016","author":"B Adamczyk","year":"2016","unstructured":"Adamczyk B, Adamczyk-Sowa M (2016) New insights into the role of oxidative stress mechanisms in the pathophysiology and treatment of multiple sclerosis. Oxid Med Cell Longev 2016:1973834. https:\/\/doi.org\/10.1155\/2016\/1973834","journal-title":"Oxid Med Cell Longev"},{"key":"5348_CR147","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41398-017-0089-z","volume":"8","author":"S Rose","year":"2018","unstructured":"Rose S, Bennuri SC, Davis JE, Wynne R, Slattery JC, Tippett M et al (2018) Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism. Transl Psychiatry 8:42. https:\/\/doi.org\/10.1038\/s41398-017-0089-z","journal-title":"Transl Psychiatry"},{"key":"5348_CR148","doi-asserted-by":"publisher","first-page":"11811","DOI":"10.3390\/ijms241411811","volume":"24","author":"Y Gao","year":"2023","unstructured":"Gao Y, Tian T (2023) mTOR signaling pathway and gut microbiota in various disorders: mechanisms and potential drugs in pharmacotherapy. Int J Mol Sci 24:11811. https:\/\/doi.org\/10.3390\/ijms241411811","journal-title":"Int J Mol Sci"},{"key":"5348_CR149","doi-asserted-by":"publisher","first-page":"1519925","DOI":"10.3389\/fimmu.2025.1519925","volume":"16","author":"W Yu","year":"2025","unstructured":"Yu W, Sun S, Fu Q (2025) The role of short-chain fatty acid in metabolic syndrome and its complications: focusing on immunity and inflammation. Front Immunol 16:1519925. https:\/\/doi.org\/10.3389\/fimmu.2025.1519925","journal-title":"Front Immunol"},{"key":"5348_CR150","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neuroscience.2025.07.024","volume":"582","author":"F Nezamzadeh","year":"2025","unstructured":"Nezamzadeh F, Masroor A, Esmailkhani A, Zahedi Bialvaei A (2025) Exploring the complex interplay: insulin resistance and gut microbiome dysbiosis in multiple sclerosis. Neuroscience 582:134\u2013145. https:\/\/doi.org\/10.1016\/j.neuroscience.2025.07.024","journal-title":"Neuroscience"},{"key":"5348_CR151","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.2147\/JIR.S300989","volume":"14","author":"MT Siddiqui","year":"2021","unstructured":"Siddiqui MT, Cresci GAM (2021) The immunomodulatory functions of butyrate. J Inflamm Res 14:6025\u20136041. https:\/\/doi.org\/10.2147\/JIR.S300989","journal-title":"J Inflamm Res"},{"key":"5348_CR152","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/db08-1637","volume":"58","author":"Z Gao","year":"2009","unstructured":"Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M et al (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58:1509\u20131517. https:\/\/doi.org\/10.2337\/db08-1637","journal-title":"Diabetes"},{"key":"5348_CR153","doi-asserted-by":"publisher","first-page":"e541","DOI":"10.1016\/j.clcc.2018.05.001","volume":"17","author":"J Chen","year":"2018","unstructured":"Chen J, Vitetta L (2018) Inflammation-modulating effect of butyrate in the prevention of colon cancer by dietary fiber. Clin Colorectal Cancer 17:e541\u2013e544. https:\/\/doi.org\/10.1016\/j.clcc.2018.05.001","journal-title":"Clin Colorectal Cancer"},{"key":"5348_CR154","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1073689","volume":"17","author":"E Mormone","year":"2023","unstructured":"Mormone E, Iorio EL, Abate L, Rodolfo C (2023) Sirtuins and redox signaling interplay in neurogenesis, neurodegenerative diseases, and neural cell reprogramming. Front Neurosci 17:1073689. https:\/\/doi.org\/10.3389\/fnins.2023.1073689","journal-title":"Front Neurosci"},{"key":"5348_CR155","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1380476","volume":"15","author":"J Kopczy\u0144ska","year":"2024","unstructured":"Kopczy\u0144ska J, Kowalczyk M (2024) The potential of short-chain fatty acid epigenetic regulation in chronic low-grade inflammation and obesity. Front Immunol 15:1380476. https:\/\/doi.org\/10.3389\/fimmu.2024.1380476","journal-title":"Front Immunol"},{"key":"5348_CR156","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.3390\/ijms25137379","volume":"25","author":"Y Du","year":"2024","unstructured":"Du Y, He C, An Y, Huang Y, Zhang H, Fu W et al (2024) The role of short chain fatty acids in inflammation and body health. Int J Mol Sci 25:7379. https:\/\/doi.org\/10.3390\/ijms25137379","journal-title":"Int J Mol Sci"},{"key":"5348_CR157","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrm.2016.140","volume":"18","author":"BR Sabari","year":"2017","unstructured":"Sabari BR, Zhang D, Allis CD, Zhao Y (2017) Metabolic regulation of gene expression through histone acylations. Nat Rev Mol Cell Biol 18:90\u2013101. https:\/\/doi.org\/10.1038\/nrm.2016.140","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5348_CR158","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02404-2","volume":"19","author":"IL Salazar","year":"2022","unstructured":"Salazar IL, Louren\u00e7o AST, Manadas B et al (2022) Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis. J Neuroinflammation 19:44. https:\/\/doi.org\/10.1186\/s12974-022-02404-2","journal-title":"J Neuroinflammation"},{"key":"5348_CR159","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/ibd\/izz046","volume":"25","author":"L Chen","year":"2019","unstructured":"Chen L, Sun M, Wu W, Yang W, Huang X, Xiao Y et al (2019) Microbiota metabolite butyrate differentially regulates Th1 and Th17 cells\u2019 differentiation and function in induction of colitis. Inflamm Bowel Dis 25:1450\u20131461. https:\/\/doi.org\/10.1093\/ibd\/izz046","journal-title":"Inflamm Bowel Dis"},{"key":"5348_CR160","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.3390\/ijms25042255","volume":"25","author":"GL Cipriano","year":"2024","unstructured":"Cipriano GL, Schepici G, Mazzon E, Anchesi I (2024) Multiple sclerosis: roles of miRNA, lncRNA, and circRNA and their implications in cellular pathways. Int J Mol Sci 25:2255. https:\/\/doi.org\/10.3390\/ijms25042255","journal-title":"Int J Mol Sci"},{"key":"5348_CR161","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2013.09.019","volume":"266","author":"J Zhang","year":"2014","unstructured":"Zhang J, Cheng Y, Cui W, Li M, Li B, Guo L (2014) Microrna-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol 266:56\u201363. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.09.019","journal-title":"J Neuroimmunol"},{"key":"5348_CR162","doi-asserted-by":"publisher","first-page":"12767","DOI":"10.3390\/ijms241612767","volume":"24","author":"I Gilyazova","year":"2023","unstructured":"Gilyazova I, Asadullina D, Kagirova E, Sikka R, Mustafin A, Ivanova E et al (2023) MiRNA-146a\u2013a key player in immunity and diseases. Int J Mol Sci 24:12767. https:\/\/doi.org\/10.3390\/ijms241612767","journal-title":"Int J Mol Sci"},{"key":"5348_CR163","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.3390\/cells11223642","volume":"11","author":"F Feng","year":"2022","unstructured":"Feng F, Jiao P, Wang J, Li Y, Bao B, Luoreng Z, Wang X (2022) Role of long noncoding RNAs in the regulation of cellular immune response and inflammatory diseases. Cells 11:3642. https:\/\/doi.org\/10.3390\/cells11223642","journal-title":"Cells"},{"key":"5348_CR164","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.15252\/embr.201643668","volume":"18","author":"D Sun","year":"2017","unstructured":"Sun D, Yu Z, Fang X, Liu M, Pu Y, Shao Q et al (2017) LncRNA GAS5 inhibits microglial M2 polarization and exacerbates demyelination. EMBO Rep 18:1801\u20131816. https:\/\/doi.org\/10.15252\/embr.201643668","journal-title":"EMBO Rep"},{"key":"5348_CR165","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bbadis.2010.05.012","volume":"1812","author":"AE Lovett-Racke","year":"2011","unstructured":"Lovett-Racke AE, Yang Y, Racke MK (2011) Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Biochim Biophys Acta 1812:246\u2013251. https:\/\/doi.org\/10.1016\/j.bbadis.2010.05.012","journal-title":"Biochim Biophys Acta"},{"key":"5348_CR166","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/brainsci15020167","volume":"15","author":"B Arneth","year":"2025","unstructured":"Arneth B (2025) Gut-brain axis and brain microbiome interactions from a medical perspective. Brain Sci 15:167. https:\/\/doi.org\/10.3390\/brainsci15020167","journal-title":"Brain Sci"},{"key":"5348_CR167","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","volume":"15","author":"M Ratti","year":"2020","unstructured":"Ratti M, Lampis A, Ghidini M, Salati M, Mirchev MB, Valeri N et al (2020) MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside. Target Oncol 15:261\u2013278. https:\/\/doi.org\/10.1007\/s11523-020-00717-x","journal-title":"Target Oncol"},{"key":"5348_CR168","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41582-021-00519-3","volume":"17","author":"N Makhani","year":"2021","unstructured":"Makhani N, Tremlett H (2021) The multiple sclerosis prodrome. Nat Rev Neurol 17:515\u2013521. https:\/\/doi.org\/10.1038\/s41582-021-00519-3","journal-title":"Nat Rev Neurol"},{"key":"5348_CR169","first-page":"150","volume":"32","author":"SH Tsai","year":"2024","unstructured":"Tsai SH et al (2024) Altered gut microbiota and metabolic profiles in high-risk individuals before multiple sclerosis diagnosis. Cell Host Microbe 32:150\u2013165","journal-title":"Cell Host Microbe"},{"key":"5348_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103798","volume":"76","author":"C Cantoni","year":"2022","unstructured":"Cantoni C, Lin Q, Dorsett Y, Ghezzi L, Liu Z, Pan Y et al (2022) Alterations of host-gut microbiome interactions in multiple sclerosis. EBioMedicine 76:103798. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103798","journal-title":"EBioMedicine"},{"key":"5348_CR171","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41573-022-00477-5","volume":"21","author":"L Bierhansl","year":"2022","unstructured":"Bierhansl L, Hartung HP, Aktas O, Ruck T, Roden M, Meuth SG (2022) Thinking outside the box: non-canonical targets in multiple sclerosis. Nat Rev Drug Discov 21:578\u2013600. https:\/\/doi.org\/10.1038\/s41573-022-00477-5","journal-title":"Nat Rev Drug Discov"},{"key":"5348_CR172","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143774","volume":"131","author":"L Ghezzi","year":"2021","unstructured":"Ghezzi L, Cantoni C, Pinget GV, Zhou Y, Piccio L (2021) Targeting the gut to treat multiple sclerosis. J Clin Invest 131:e143774. https:\/\/doi.org\/10.1172\/JCI143774","journal-title":"J Clin Invest"},{"key":"5348_CR173","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12916-020-01602-3","volume":"18","author":"AJ Forgie","year":"2020","unstructured":"Forgie AJ, Drall KM, Bourque SL et al (2020) The impact of maternal and early life malnutrition on health: a diet-microbe perspective. BMC Med 18:135. https:\/\/doi.org\/10.1186\/s12916-020-01602-3","journal-title":"BMC Med"},{"key":"5348_CR174","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.4049\/jimmunol.2300016","volume":"210","author":"W Zhang","year":"2023","unstructured":"Zhang W, Mackay CR, Gershwin ME (2023) Immunomodulatory effects of microbiota-derived short-chain fatty acids in autoimmune liver diseases. J Immunol 210:1629\u20131639. https:\/\/doi.org\/10.4049\/jimmunol.2300016","journal-title":"J Immunol"},{"key":"5348_CR175","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1552-y","volume":"16","author":"T Chen","year":"2019","unstructured":"Chen T, Noto D, Hoshino Y, Mizuno M, Miyake S (2019) Butyrate suppresses demyelination and enhances remyelination. J Neuroinflammation 16:165. https:\/\/doi.org\/10.1186\/s12974-019-1552-y","journal-title":"J Neuroinflammation"},{"key":"5348_CR176","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.59826","volume":"10","author":"AV Colombo","year":"2021","unstructured":"Colombo AV, Sadler RK, Llovera G, Singh V, Roth S, Heindl S et al (2021) Microbiota-derived short chain fatty acids modulate microglia and promote A\u03b2 plaque deposition. Elife 10:e59826. https:\/\/doi.org\/10.7554\/eLife.59826","journal-title":"Elife"},{"key":"5348_CR177","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s13317-021-00149-1","volume":"12","author":"A Becker","year":"2021","unstructured":"Becker A, Abuazab M, Schwiertz A, Walter S, Fa\u00dfbender KC, Fousse M et al (2021) Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products? Auto Immun Highlights 12:7. https:\/\/doi.org\/10.1007\/s13317-021-00149-1","journal-title":"Auto Immun Highlights"},{"key":"5348_CR178","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2274126","author":"D Kujawa","year":"2023","unstructured":"Kujawa D, Laczmanski L, Budrewicz S, Pokryszko-Dragan A, Podbielska M (2023) Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis. Gut Microbes. https:\/\/doi.org\/10.1080\/19490976.2023.2274126","journal-title":"Gut Microbes"},{"key":"5348_CR179","doi-asserted-by":"publisher","first-page":"15292","DOI":"10.1038\/s41598-024-64369-x","volume":"14","author":"TL Montgomery","year":"2024","unstructured":"Montgomery TL, Wang Q, Mirza A, Dwyer D, Wu Q, Dowling CA et al (2024) Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis. Sci Rep 14:15292. https:\/\/doi.org\/10.1038\/s41598-024-64369-x","journal-title":"Sci Rep"},{"key":"5348_CR180","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.brainresbull.2024.03.005","volume":"205","author":"Y Tang","year":"2024","unstructured":"Tang Y, Zhao D, Ma Q, Liu C, Yang X (2024) Butyrate enhances mitochondrial biogenesis and energy metabolism in glial cells: implications for neurodegeneration. Brain Res Bull 205:96\u2013105. https:\/\/doi.org\/10.1016\/j.brainresbull.2024.03.005","journal-title":"Brain Res Bull"},{"key":"5348_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2023.105425","volume":"168","author":"T Ghosh","year":"2023","unstructured":"Ghosh T, Roy A, Talukdar A (2023) Stability and bioavailability of SCFAs: barriers to therapeutic application in neurodegenerative disorders. Neurochem Int 168:105425. https:\/\/doi.org\/10.1016\/j.neuint.2023.105425","journal-title":"Neurochem Int"},{"key":"5348_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114566","volume":"370","author":"J Liu","year":"2024","unstructured":"Liu J, Liang Y, Tang H, Wu H, Wang Q, Xu X (2024) Butyrate mitigates neurodegeneration by stabilizing synaptic structure and microglial phenotype in chronic EAE. Exp Neurol 370:114566. https:\/\/doi.org\/10.1016\/j.expneurol.2024.114566","journal-title":"Exp Neurol"},{"key":"5348_CR183","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/08820139.2015.1122613","volume":"45","author":"M Asarat","year":"2016","unstructured":"Asarat M, Apostolopoulos V, Vasiljevic T, Donkor O (2016) Short-chain fatty acids regulate cytokines and Th17\/Treg cells in human peripheral blood mononuclear cells in vitro. Immunol Invest 45:205\u2013222. https:\/\/doi.org\/10.3109\/08820139.2015.1122613","journal-title":"Immunol Invest"},{"key":"5348_CR184","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021806","volume":"24","author":"L Calvo-Barreiro","year":"2023","unstructured":"Calvo-Barreiro L, Zhang L, Abdel-Rahman SA, Naik SP, Gabr M (2023) Gut microbial-derived metabolites as immune modulators of T helper 17 and regulatory T cells. Int J Mol Sci 24:1806. https:\/\/doi.org\/10.3390\/ijms24021806","journal-title":"Int J Mol Sci"},{"key":"5348_CR185","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063198","volume":"25","author":"L Barcutean","year":"2024","unstructured":"Barcutean L, Maier S, Burai-Patrascu M, Farczadi L, Balasa R (2024) The immunomodulatory potential of short-chain fatty acids in multiple sclerosis. Int J Mol Sci 25:3198. https:\/\/doi.org\/10.3390\/ijms25063198","journal-title":"Int J Mol Sci"},{"key":"5348_CR186","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.msard.2016.07.001","volume":"9","author":"V Yadav","year":"2016","unstructured":"Yadav V, Marracci G, Kim E, Spain R, Cameron M, Overs S et al (2016) Low-fat, plant-based diet in multiple sclerosis: a randomized controlled trial. Mult Scler Relat Disord 9:80\u201390. https:\/\/doi.org\/10.1016\/j.msard.2016.07.001","journal-title":"Mult Scler Relat Disord"},{"key":"5348_CR187","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.3390\/nu17152501","volume":"17","author":"Y-C Yang","year":"2025","unstructured":"Yang Y-C, Chang S-C, Hung C-S, Shen M-H, Lai C-L, Huang C-J (2025) Gut-microbiota-derived metabolites and probiotic strategies in colorectal cancer: implications for disease modulation and precision therapy. Nutrients 17:2501. https:\/\/doi.org\/10.3390\/nu17152501","journal-title":"Nutrients"},{"key":"5348_CR188","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/biology14040435","volume":"14","author":"MH Nemati","year":"2025","unstructured":"Nemati MH, Yazdanpanah E, Kazemi R, Orooji N, Dadfar S, Oksenych V et al (2025) Microbiota-driven mechanisms in multiple sclerosis: pathogenesis, therapeutic strategies, and biomarker potential. Biology 14:435. https:\/\/doi.org\/10.3390\/biology14040435","journal-title":"Biology"},{"key":"5348_CR189","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cell.2020.02.035","volume":"180","author":"A Duscha","year":"2020","unstructured":"Duscha A, Gisevius B, Hirschberg S, Yissachar N, Stangl GI, Eilers E et al (2020) Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism. Cell 180:1067-1080.e16. https:\/\/doi.org\/10.1016\/j.cell.2020.02.035","journal-title":"Cell"},{"key":"5348_CR190","doi-asserted-by":"publisher","first-page":"18577","DOI":"10.1038\/s41598-023-46047-6","volume":"13","author":"KM Asghari","year":"2023","unstructured":"Asghari KM, Dolatkhah N, Ayromlou H et al (2023) The effect of probiotic supplementation on the clinical and para-clinical findings of multiple sclerosis: a randomized clinical trial. Sci Rep 13:18577. https:\/\/doi.org\/10.1038\/s41598-023-46047-6","journal-title":"Sci Rep"},{"key":"5348_CR191","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.661493","volume":"12","author":"A Olsson","year":"2021","unstructured":"Olsson A, Gustavsen S, Nguyen TD, Nyman M, Langkilde AR, Hansen TH et al (2021) Serum short-chain fatty acids and associations with inflammation in newly diagnosed patients with multiple sclerosis and healthy controls. Front Immunol 12:661493. https:\/\/doi.org\/10.3389\/fimmu.2021.661493","journal-title":"Front Immunol"},{"key":"5348_CR192","doi-asserted-by":"publisher","first-page":"17511","DOI":"10.1038\/s41598-019-54276-x","volume":"9","author":"J Park","year":"2019","unstructured":"Park J, Wang Q, Wu Q, Mao-Draayer Y, Kim CH (2019) Author correction: bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation. Sci Rep 9:17511. https:\/\/doi.org\/10.1038\/s41598-019-54276-x","journal-title":"Sci Rep"},{"key":"5348_CR193","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.celrep.2019.04.022","volume":"27","author":"J Qiu","year":"2019","unstructured":"Qiu J, Villa M, Sanin DE, Buck MD, O\u2019Sullivan D, Ching R et al (2019) Acetate promotes T cell effector function during glucose restriction. Cell Rep 27:2063-2074.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.04.022","journal-title":"Cell Rep"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05348-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05348-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05348-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:02:56Z","timestamp":1762977776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05348-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":193,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5348"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05348-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not applicable for this study as it did not involve human participants, animal subjects, or clinical trials.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable (I confirm that the present work does not involve a clinical trial or interventional study involving human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Registration"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}